traceability and uncertaintyobjednavky.roche-diagnostics.cz/objednavky/info/...cholesterol chod-pap...
TRANSCRIPT
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
Routine Method
Hitachi SystemsACN Reference Method Reference Material
Selected Measurement
ProcedureAssigned Value Uncertainty 1 Unit
ATRYP
Antitrypsin alpha 1
immunoturbidimetric
048 ERM-DA470k/IFCC9 136
1.36
1.84
0.0184
mg/dL
g/L
GPROT
Acid glycoprotein alpha 1
immunoturbidimetric
229 CRM 4702 88.5
0.885
1.39
0.0139
mg/dL
g/L
ACPAcid phosphatase total
1-naphthyl phosphate
021Roche reagent, manual measurement
0.72043.1
0.007030.421
µkat/LU/L
ACP-NPPAcid phosphatase, non-prostatic
1-naphthyl phosphate(Inhib.:tartrate)
022Roche reagent, manual measurement
0.41825.0
0.008050.482
µkat/LU/L
ACP-PAcid phosphatise, prostatic
1-naphthyl phosphate(Inhib.:tartrate)
- calculated0.30218.1
0.01070.640
µkat/LU/L
ALB
Albumin BCG plus
413 ERM-DA470k/IFCC9 4830
48.3
52.9
0.529
mg/dL
g/L
ALB
Albumin BCP
760 ERM-DA470k/IFCC9 4500
45.0
46.0
0.460
mg/dL
g/L
ALB2
Albumin immunoturbidimetric
412 ERM-DA470k/IFCC9 4.42
44.2
0.0668
0.668
g/dL
g/L
ALP
Alkaline phosphataseIFCC liquid
158Original formulation
IFCC5 (Tietz, 1983),
manual measurement
202 1.48 U/L
ALP
Alkaline phosphatase
IFCC liquid
158Original formulation
IFCC5 (Schumann, 2011),
manual measurement
230 2.16 U/L
ALP
Alkaline phosphatase
opt. (DGKC)
683Roche reagent, manual
measurement413 4.19 U/L
ALT
Alanine aminotransferase
IFCC with pyridoxal phosphate
684Original formulation
IFCC5 (2002), manual
measurement
1.94
116
0.0153
0.917
µkat/L
U/L
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
Routine Method
Hitachi SystemsACN Reference Method Reference Material
Selected Measurement
ProcedureAssigned Value Uncertainty 1 Unit
ALT
Alanine aminotransferase
IFCC without pyridoxal phosphate
685Original formulation
IFCC5 (2002) modified,
manual measurement
1.94
116
0.0153
0.917
µkat/L
U/L
ALT
Alanine aminotransferase
IFCC without pyridoxal phosphate HiCo
176Original formulation
IFCC5 (2002) modified,
manual measurement
1.94
116
0.0153
0.917
µkat/L
U/L
AMY-L
Amylase alpha
IFCC liquid
570Roche reagent according
to IFCC5 (1998), manual
measurement
2.94
176
0.0261
1.56
µkat/L
U/L
AMY-L
Amylase alpha
IFCC liquid STAT
566Roche reagent according
to IFCC5 (1998), manual
measurement
2.94
176
0.0261
1.56
µkat/L
U/L
P-AMY
Amylase alpha pancreatic
ESP liquid
571Roche reagent, manual
measurement
1.57
94.0
0.0105
0.628
µkat/L
U/L
APOAT
Apolipoprotein A-I
immunoturbidimetric ver. 2
168WHO international
reference material
SP1-01
144
1.44
4.24
0.0424
mg/dL
g/L
APOALApolipoprotein A-I
immunoturbidimetric ver. 2
436WHO international reference material
SP1-01
1441.44
4.240.0424
mg/dLg/L
APOBTApoliprotein B
immunoturbidimetric ver. 2
151WHO international reference material
SP3-07
61.50.615
4.700.0470
mg/dLg/L
APOBLApoliprotein B
immunoturbidimetric ver. 2
199WHO international reference material
SP3-07
61.50.615
4.700.0470
mg/dLg/L
ASLOAntistreptolysin 0
immunoturbidimetric
037Internal standard material
248 2.92 IU/mL
AST
Aspartate aminotransferaseIFCC with pyridoxal phosphate
686Original formulation
IFCC5 (2002), manual
measurement
2.27
136
0.0163
0.979
µkat/L
U/L
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
Routine Method
Hitachi SystemsACN Reference Method Reference Material
Selected Measurement
ProcedureAssigned Value Uncertainty 1 Unit
AST
Aspartate aminotransferase
IFCC without pyridoxal phosphate
687Original formulation
IFCC5 (2002) modified,
manual measurement
2.27
136
0.0163
0.979
µkat/L
U/L
BILD2
Bilirubin direct
Diazo Gen. 2Jendrassik-Grof
734Roche reagent, manual
measurement(Jendrassik-Grof)
2.16
37.0
0.0153
0.262
mg/dL
µmol/L
BILD2Bilirubin direct
Diazo Gen. 2 Doumas
727Roche reagent, manual measurement
(Doumas)
1.8431.5
0.01300.223
mg/dL µmol/L
TBILIBilirubin total
liquid STAT
018acc. to Doumas 3.80
65.00.08541.46
mg/dLµmol/L
BILT3Bilirubin total
DPD Gen. 3
712 acc. to Doumas 3.8265.3
0.05650.966
mg/dLµmol/L
BUN Blood urea nitrogen
kinetic UV
421 ID-MS4 66.123.6
1.280.456
mg/dLmmol/L
BUN
Blood urea nitrogenkinetic UV STAT
427 ID-MS4 66.1
23.6
1.28
0.456
mg/dL
mmol/L
Ca
Calcium o-cresolphthaleine complexone
726 SRM 956c L33 13.4
3.34
0.0838
0.0209
mg/dL
mmol/L
Ca
Calcium o-cresolphthaleine complexone STAT
706 SRM 956c L33 13.4
3.34
0.0838
0.0209
mg/dL
mmol/L
Ca2
Calcium nM-BAPTA
698 SRM 956c L23 13.5
3.36
0.158
0.0394
mg/dL
mmol/L
Ca2
Calcium
nM-BAPTA STAT
699 SRM 956c L23 13.5
3.36
0.158
0.0394
mg/dL
mmol/L
C3C
Complement C3c
immunoturbidimetric
036 CRM 4702 149
1.49
1.26
0.0126
mg/dL
g/L
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
Routine Method
Hitachi SystemsACN Reference Method Reference Material
Selected Measurement
ProcedureAssigned Value Uncertainty 1 Unit
C4
Complement C4
immunoturbidimetric
032 ERM-DA470k/IFCC9 25.3
0.253
0.295
0.00295
mg/dL
g/L
CPLA2
Ceruloplasmin
immunoturbidimetric
709 CRM 4702 30.5
0.305
0.507
0.00507
mg/dL
g/L
CHECholinesterase
acethylthiocholine
725Roche reagent, manual measurement
51.43080
0.53832.2
µkat/LU/L
CHECholinesterase
butyrylthiocholine Gen.2
510Roche reagent, manual measurement
1026120
0.96958.0
µkat/LU/L
CHOLCholesterol
CHOD-PAP stand. ID/MS
433 ID-MS4 5.10 0.036510
mmol/L
CHOLCholesterol
CHOD-PAP stand. Abell-Kendall
433 Abell-Kendall 5.18 0.037110
mmol/L
CK
Creatine kinase IFCC liquid
057Original formulation
IFCC5 (2002), manual
measurement
4.99
299
0.0287
1.72
µkat/L
U/L
CK-MB
Creatine kinase-MBliquid
060Original formulation
IFCC5 (2002) modified,
manual measurement
1.26
75.7
0.0187
1.12
µkat/L
U/L
CREA
Creatinine
plus
652 ID-MS4 3.73
330
0.0314
2.78
mg/dL
µmol/L
CREA
Creatinine
Jaffé compensated STAT
773 ID-MS4 3.86
342
0.0571
5.05
mg/dL
µmol/L
CREACreatinine
Jaffé rate-blanked and compensated
690 ID-MS4 4.16368
0.04904.34
mg/dLµmol/L
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
Routine Method
Hitachi SystemsACN Reference Method Reference Material
Selected Measurement
ProcedureAssigned Value Uncertainty 1 Unit
CRPL3
C-Reactive Protein
immunoturbidimetric Gen. 3
Mod P: 210Mod D: 200
CRM 4702
32.9
3.29
313
0.664
0.0664
6.32
mg/L
mg/dL
nmol/L
Fe
Iron
FerroZine
661 SRM 9373 231
41.3
2.72
0.486
µg/dL
µmol/L
Ferr4Ferritin
particle enhanced test Gen. 4
692NIBSC
8Reagent Ferritin
(human liver) 08/602199447
2.285.12
µg/Lpmol/L
GGT
Glutamyltransferase gamma
liquid stand. Szasz
479Original formulation
Persijn/v.d. Slik (1976),
manual measurement
3.41
204
0.0473
2.83
µkat/L
U/L
GGTGlutamyltransferase gamma
liquid stand. Szasz HiCo
480Original formulation Persijn/v.d. Slik (1976),
manual measurement
3.41204
0.04732.83
µkat/LU/L
GGTGlutamyltransferase gamma
liquid stand. IFCC
219Original formulation IFCC
5 (2002), manual
measurement
3.86231
0.06103.65
µkat/LU/L
GGTGlutamyltransferase gamma
liquid stand. IFCC HiCo
220Original formulation IFCC
5 (2002), manual
measurement
3.86231
0.06103.65
µkat/LU/L
GLDHGlutamate dehydrogenase
opt. (DGKC)
588Roche reagent, manual measurement
0.67140.2
0.01040.622
µkat/LU/L
GLU
Glucose GOD-PAP
525 ID-MS4 229
12.7
2.61
0.145
mg/dL
mmol/L
GLU
Glucose HK
668 ID-MS4 229
12.7
2.61
0.145
mg/dL
mmol/L
GLU
Glucose HK STAT
767 ID-MS4 229
12.7
2.61
0.145
mg/dL
mmol/L
GLUH2
Glucose hemolysate Gen. 2
409 ID-MS4 229
12.7
2.61
0.145
mg/dL
mmol/L
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
Routine Method
Hitachi SystemsACN Reference Method Reference Material
Selected Measurement
ProcedureAssigned Value Uncertainty 1 Unit
HBDH
Hydroxybutyrate dehydrogenase
alphaopt. (DGKC)
567Roche reagent, manual
measurement
5.03
301
0.0705
4.22
µkat/L
U/L
HDLC3
HDL-Cholesterolplus 3
rd generation
435
According to the CDC7
referencemethod [Precipitation by
dextran
sulphate and Abell-Kendall]
1.49 0.0399 mmol/L
HGLOB
Haptoglobin
immunoturbidimetric
228 ERM-DA470k/IFCC9 119
1.19
1.63
0.0163
mg/dL
g/L
IGA-2
Immunoglobulin A
immunoturbidimetric Gen.2 standard
458 CRM 4702
2.29 0.027111
g/L
IGG-2
Immunoglobulin G
immunoturbidimetric Gen.2 standard
674 ERM-DA470k/IFCC9 1160
11.6
8.88
0.0888
mg/dL
g/L
IGM-2Immunoglobulin M
immunoturbidimetric Gen.2 standard
465 CRM 4702
1.01 0.015011
g/L
KAPPAKappa
immunoturbidimetric
283CRM 470
2
(calculated over Lievens
equation)
3233.23
4,390.0439
mg/dLg/L
LAC
Lactateenzymatic colorimetric test
040Primary reference
material (weighed in purified material)
3.63 0.0264 mmol/L
LAMBD
Lambdaimmunoturbidimetric
284CRM 470
2
(calculated over Lievens equation)
177
1.77
2.51
0.0251
mg/dL
g/L
LDH
Lactate dehydrogenase IFCC liquid
080Original formulation
IFCC5 (2002), manual
measurement
5.06
303
0.0357
2.14
µkat/L
U/L
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
Routine Method
Hitachi SystemsACN Reference Method Reference Material
Selected Measurement
ProcedureAssigned Value Uncertainty 1 Unit
LDH
Lactate dehydrogenase
IFCC liquid with automatic sample pre-dilution
147Original formulation
IFCC5 (2002), manual
measurement
5.06
303
0.0357
2.14
µkat/L
U/L
LDH
Lactate dehydrogenaseopt.(DGKC)
672Roche reagent, manual
measurement
9.67
579
0.106
6.35
µkat/L
U/L
LDLC2
LDL-Cholesterol
plus 2nd generation
059
According to CDC7beta
quantificationmethod [Precipitation by heparinmanganese(ultracentrifugation) and
Abell-Kendall]
2.60 0.0421 mmol/L
LIP
Lipase
enzymatic colorimetric test
731Roche reagent, manual
measurement
1.58
94.4
0.0169
1.01
µkat/L
U/L
LIP
Lipase
enzymatic colorimetric test STAT
733Roche reagent, manual
measurement
1.58
94.4
0.0169
1.01
µkat/L
U/L
MG
Magnesium
xylidyl blue method
693 Atomic absorption1.32
3.21
0.00646
0.0157
mmol/L
mg/dL
MGMagnesium
xylidyl blue method STAT
770 Atomic absorption1.323.21
0.006460.0157
mmol/Lmg/dL
PALB2Prealbumin
immunoturbidimetric
710ERM-DA470k/IFCC
9
27.80.278
0.4170.00417
mg/dLg/L
PALBLPrealbumin
immunoturbidimetric
546ERM-DA470k/IFCC
9
27.80.278
0.4170.00417
mg/dLg/L
PHOSPhosphate (inorganic)
molybdate UV
714
Primary reference material (NERL)
(weighed in purified
material)
6.202.00
0.05830.0188
mg/dLmmol/L
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
Routine Method
Hitachi SystemsACN Reference Method Reference Material
Selected Measurement
ProcedureAssigned Value Uncertainty 1 Unit
PHOS
Phosphate (inorganic)
molybdate UV STAT
675
Primary reference
material (NERL)
(weighed in purified material)
6.20
2.00
0.0583
0.0188
mg/dL
mmol/L
TRSF2
Transferinimmunoturbidimetric
Mod P: 187Mod D: 231
CRM 4702
3.37
337
0.0462
4.62
g/L
mg/dL
TG
Triglycerides
GPO-PAP
781 ID-MS4 2.47 0.0278 mmol/L
TG
Triglycerides
GPO-PAP GB
783 SRM 909b 349.6
0.560
0.735
0.00830
mg/dL
mmol/L
TP
Total protein
Biuret
678 SRM 927d 37.65
76.5
0.0516
0.516
g/dL
g/L
TP
Total protein
Biuret STAT
679 SRM 927d 37.65
76.5
0.0516
0.516
g/dL
g/L
UAUric acid
plus
700 ID-MS4 12.1722
0.05583.32
mg/dLµmol/L
UREAUrea
kinetiv UV
418 ID-MS4 14223.6
2.740.456
mg/dLmmol/L
UREAUrea
kinetiv UV STAT
419 ID-MS4 14223.6
2.740.456
mg/dLmmol/L
1 This uncertainty (expanded uncertainty; k = 2) was calculated in accordance with the “Guide to the expression of uncertainty in measurement” (GUM: 1993). For the estimation of the single standard uncertainties normal distribution of the measurement results is assumed; the level of confidence of the expanded uncertainty is about 95% with the coverage factor k=2 (analogue to the 2sd of the standard uncertainty).
2 CRM = Certified Reference Material, European3 SRM = Standard Reference Material4 ID-MS = Isotope Dilution - Mass Spectrometry5 IFCC = International Federation of clinical chemistry and laboratory medicine
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2
Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)
Roche Diagnostics GmbH März 2018
6 WHO = World Health Organisation7 CDC = Centre for Disease Control8 NIBSC = National Institute for Biological Standards and Control9 ERM-DA470k/IFCC = European Reference Materials10 The value describes the uncertainty within a system class. By transferring the setpoint from one system class to another an additional systematic deviation can arise. This deviation
is limited by the instrument to instrument specification. The relative maximum deviation is 5 %, resp. CHOL 0.1 mmol/L.11 The value describes the uncertainty within a system class. By transferring the setpoint from one system class to another an additional systematic deviation can arise. This deviation
is limited by the instrument to instrument specification. The relative maximum deviation is 10 %, resp. 0.1 g/L IgA or 0.03 g/L IgM.